Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

High Risk Multiple Myeloma Prognosis with Dr. Sagar Lonial

  • Broadcast in Health
  • 0 comments
CureTalks

CureTalks

×  

Follow This Show

If you liked this show, you should follow CureTalks.
h:350019
s:6742509
archived

We are talking about high-risk multiple myeloma and its prognosis with Dr. Sagar Lonial this August. Make sure REGISTER in advance to ask Dr. Lonial your myeloma question. 

Dr. Lonial is Professor at the Winship Cancer Institute of Emory University, Director of Translational Research, B-cell malignancy program as well as Associate Director of Hematology Oncology Fellowship Program. He staffs and works both on the transplant service as well as in the B-cell malignancy clinic. Dr. Lonial completed his Hematology-Oncology training at Emory University, and prior to that received his internal medicine residency at the Baylor College of Medicine in Houston Texas. There he spent an additional year as a Chief Medical Resident at the Ben Taub General Hospital as well as the Texas Heart Institute and St Lukes Hospital. Dr. Lonial is on the editorial board for Clinical Lymphoma and Myeloma and The American Journal of Clinical Oncology, as well as an ad hoc reviewer for Blood, Cancer Research, Clinical Cancer Research, Haematologica, and other journals. He has authored or co-authored over 40 papers and abstracts, and was recently appointed to Vice-chair for the ECOG myeloma committee.

 

Comments

 comments